Biperiden


Generic Medicine Info
Administration
Should be taken with food.
Contraindications
Untreated narrow-angle glaucoma, mechanical stenoses in the GI tract, paralytic ileus, megacolon, prostatic adenoma and diseases that can lead to perilous tachycardia.
Special Precautions
Patient w/ thyrotoxicosis, cardiac failure, tachycardia, and those at risk of convulsions. Avoid abrupt withdrawal. Elderly. Pregnancy and lactation. Patient Counselling This drug may cause drowsiness, dizziness or blurred vision, if affected, do not drive or operate machinery.
Adverse Reactions
Urinary retention, dry mouth, constipation, nausea, vomiting, dyspepsia, blurred vision, mydriasis, dry eyes, tachycardia, arrhythmia, dizziness, drowsiness, headache, hallucinations, memory impairment, confusion, insomnia, worsening of dyskinesia, generalised choreic movements, fever due to anhidrosis, rash, flushed skin, dry skin, hypersensitivity reactions.
Drug Interactions
Increased CNS and peripheral side effects w/ anticholinergic psychotropic drugs, antihistamines, other antiparkinsonian drugs and antispasmodics. May potentiate dyskinesia w/ levodopa. Increased anticholinergic effects w/ quinidine. May reduce the effect of metoclopramide and other compounds w/ similar activity on the GI tract. May antagonise the therapeutic effects of anticholinesterases.
ATC Classification
N04AA02 - biperiden ; Belongs to the class of tertiary amines anticholinergic agents. Used in the management of Parkinson's disease.
Disclaimer: This information is independently developed by CIMS based on biperiden from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in